Increased Dosage of Dyrk1A Alters Alternative Splicing Factor (ASF)-regulated Alternative Splicing of Tau in Down Syndrome
Open Access
- 1 October 2008
- journal article
- Published by Elsevier BV in Journal of Biological Chemistry
- Vol. 283 (42), 28660-28669
- https://doi.org/10.1074/jbc.m802645200
Abstract
No abstract availableKeywords
This publication has 55 references indexed in Scilit:
- SR protein 9G8 modulates splicing of tau exon 10 via its proximal downstream intron, a clustering region for frontotemporal dementia mutationsMolecular and Cellular Neuroscience, 2007
- Regulation of phosphorylation of tau by cyclin‐dependent kinase 5 and glycogen synthase kinase‐3 at substrate levelFEBS Letters, 2006
- NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21Nature, 2006
- Tau Exons 2 and 10, Which Are Misregulated in Neurodegenerative Diseases, Are Partly Regulated by Silencers Which Bind a SRp30c·SRp55 Complex That Either Recruits or Antagonizes htra2β1Published by Elsevier BV ,2005
- Tau pathology in Alzheimer disease and other tauopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Regulation of tau isoform expression and dementiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Hyperphosphorylation and aggregation of tau in mice expressing normal human tau isoformsJournal of Neurochemistry, 2003
- Structural and Functional Differences between 3-Repeat and 4-Repeat Tau IsoformsJournal of Biological Chemistry, 2000
- Characterization of Pathology in Transgenic Mice Over-Expressing Human Genomic and cDNA Tau TransgenesNeurobiology of Disease, 2000
- A serine kinase regulates intracellular localization of splicing factors in the cell cycleNature, 1994